Whole-Exome Sequencing Reveals High Mutational Concordance between Primary and Matched Recurrent Triple-Negative Breast Cancers
Genes · 2023
DOI: 10.3390/genes14091690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2023. Verfasst von Jaspreet Kaur und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Georgia State University, Atlanta, GA 30303, USA. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Neoplasm Recurrence, Local, Mutation, Biomarkers, Tumor. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute of Health, Department of Oncology, Dell Medical School, and the Glenn Breast Cancer Research Scholar Award.
Abstract (Originalsprache)
Purpose
Triple-negative breast cancer (TNBC) is a molecularly complex and heterogeneous breast cancer subtype with distinct biological features and clinical behavior. Although TNBC is associated with an increased risk of metastasis and recurrence, the molecular mechanisms underlying TNBC metastasis remain unclear. We performed whole-exome sequencing (WES) analysis of primary TNBC and paired recurrent tumors to investigate the genetic profile of TNBC.
Methods
Genomic DNA extracted from 35 formalin-fixed paraffin-embedded tissue samples from 26 TNBC patients was subjected to WES. Of these, 15 were primary tumors that did not have recurrence, and 11 were primary tumors that had recurrence (nine paired primary and recurrent tumors). Tumors were analyzed for single-nucleotide variants and insertions/deletions.
Results
The tumor mutational burden (TMB) was 7.6 variants/megabase in primary tumors that recurred (n = 9); 8.2 variants/megabase in corresponding recurrent tumors (n = 9); and 7.3 variants/megabase in primary tumors that did not recur (n = 15). MUC3A was the most frequently mutated gene in all groups. Mutations in MAP3K1 and MUC16 were more common in our dataset. No alterations in PI3KCA were detected in our dataset.
Conclusions
We found similar mutational profiles between primary and paired recurrent tumors, suggesting that genomic features may be retained during local recurrence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Georgia State University, Atlanta, GA 30303, USA.
- Department of Pathology-Molecular and Cellular, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
- Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland.
- Department of Pathology, Stavanger University Hospital, Health Stavanger HF, 4068 Stavanger, Norway.
- Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.
- Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA.
ORCID-Profile: Darshan S Chandrashekar, Zsuzsanna Varga, Emiel Janssen, Jeanne Kowalski, Umay Kiraz, Sooryanarayana Varambally
Förderung
- NCI NIH HHS
- National Cancer Institute of Health
- Department of Oncology, Dell Medical School, and the Glenn Breast Cancer Research Scholar Award
Zitieren
APA
Kaur, J., Chandrashekar, D. S., Varga, Z., Sobottka, B., Janssen, E., Gandhi, K., Kowalski, J., Kiraz, U., Varambally, S., & Aneja, R. (2023). Whole-Exome Sequencing Reveals High Mutational Concordance between Primary and Matched Recurrent Triple-Negative Breast Cancers. Genes. https://doi.org/10.3390/genes14091690
Vancouver
Kaur J, Chandrashekar DS, Varga Z, Sobottka B, Janssen E, Gandhi K, et al. Whole-Exome Sequencing Reveals High Mutational Concordance between Primary and Matched Recurrent Triple-Negative Breast Cancers. Genes. 2023. doi:10.3390/genes14091690
BibTeX
@article{Kaur2023,
author = {Kaur, Jaspreet and Chandrashekar, Darshan S and Varga, Zsuzsanna and Sobottka, Bettina and Janssen, Emiel and Gandhi, Khanjan and Kowalski, Jeanne and Kiraz, Umay and Varambally, Sooryanarayana and Aneja, Ritu},
title = {Whole-Exome Sequencing Reveals High Mutational Concordance between Primary and Matched Recurrent Triple-Negative Breast Cancers},
journal = {Genes},
year = {2023},
doi = {10.3390/genes14091690}
}
EUVIMED